Qrons Inc (QRON) Return on Equity ROE from the fourth quarter 2024 to fourth quarter 2023 and annually, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket
 


Qrons Inc   (QRON)

Qrons Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Qrons Inc in the fourth quarter 2024?
Due to the lack of equity, it was not possible to calculate Qrons Inc 's return on equity (ROE) in its fourth quarter 2024

What is ROE?




Return On Equity (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 -1 -1 -1
Return On Equity (TTM) - - - - -
QRON's Total Ranking # # # # #
Equity (TTM) in Millions 0 -1 -1 -1 -1
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





QRON Annual Return On Equity (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Equity in Millions 0 -1 -1 -1 -1
Y / Y Equity Change - - - - -
Net Income in Millions 0 -1 -1 -1 -2
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
QRON's' Return on Equity at Yahoo Finance
QRON's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for QRON's Competitors
Subscribers only: Roe for Qrons Inc 's Suppliers
Subscribers only: Return On Equity for QRON's Customers




Companies with similar Return On Equity at Dec 31 2024, within Healthcare Sector ROE
Quest Diagnostics Inc  13.76 %
Lemaitre Vascular Inc   13.59 %
Filana Therapeutics Inc   13.42 %
Neurocrine Biosciences Inc   13.38 %
Royalty Pharma Plc  13.24 %
Avantor Inc   12.77 %
Tg Therapeutics Inc   12.43 %
Sensus Healthcare Inc   12.42 %
Precision Biosciences Inc  12.29 %
Cadre Holdings inc   12.23 %
The Pennant Group Inc   11.64 %
Kiora Pharmaceuticals Inc   11.62 %
Progyny Inc   11.53 %
Utah Medical Products Inc  11.25 %
Align Technology inc   11.01 %
National Healthcare Corp  10.62 %
Sotera Health Company  10.28 %
Krystal Biotech Inc   10.28 %
Biogen Inc   10.17 %
Henry Schein Inc   9.62 %
U S Physical Therapy Inc  9.40 %
Labcorp Holdings Inc   9.28 %
Castle Biosciences Inc   9.24 %
Merit Medical Systems Inc  9.21 %
Viemed Healthcare Inc   9.17 %
Pfizer Inc  8.92 %
Solventum Corporation  8.88 %
Acadia Healthcare Company Inc   8.87 %
Boston Scientific Corporation  8.82 %
Protalix Biotherapeutics inc   8.75 %


Date modified: 2026-09-08T15:11:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.